Figure S2 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma

Seitter, Samantha J.; Sherry, Richard M.; Yang, James Chih‐Hsin; Robbins, Paul; Shindorf, Mackenzie L.; Copeland, Amy R.; McGowan, Christine T.; Epstein, Monica; Shelton, Thomas E.; Langhan, Michelle M.; Franco, Zulmarie; Danforth, David N.; White, Daniel E.; Rosenberg, Steven A.; Goff, Stephanie L.

doi:10.1158/1078-0432.22481732

2023

DOI: 10.1158/1078-0432.22481732

|View full text |Cite

Preprint

Figure S2 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma

Samantha J. Seitter¹,

Richard M. Sherry²,

James Chih‐Hsin Yang³

et al.

Abstract: <p>Post ACT survival (MSS and PFS) data for patients with BRAF V600E/K (+) tumors with respect to prior therapy</p>

Help me understand this report

View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Figure S2 from Impact of Prior Treatment on the Efficacy of Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma

Abstract: <p>Post ACT survival (MSS and PFS) data for patients with BRAF V600E/K (+) tumors with respect to prior therapy</p>

This publication either has no citations yet, or we are still processing them

See others like this or search for similar articles

Contact Info

Product

Resources

About